Clinical Trial Update: The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Qianweitai (silodosin capsule) to tamsulosin for efficacy and safety in benign prostatic hyperplasia; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Qianweitai (Silodosin Capsule) (silodosin)
• Tamsulosin (tamsulosin)

Snippet

Sponsor: Shanghai Huilun Pharmaceutical Co., Ltd. | Conditions: BPH (Benign Prostatic Hyperplasia) | Phase 4 | Status: COMPLETED